title: Translation of Pr55(gag) augments packaging of human immunodeficiency virus type 1 RNA in a cis-acting manner.
abstract: The full-length RNA of human immunodeficiency virus type 1 (HIV-1) serves both as a messenger (mRNA) to direct the translation of Pr55(gag) proteins and as genomic or viral particle RNA (vpRNA) to be packaged into virions. In this study, we have assessed a putative cis-acting effect of Pr55(gag) translation on HIV-1 RNA packaging. To pursue this subject, we have measured the relative competence of two distinct types of HIV-1 RNA for being packaged by virus particles under conditions in which only one of them is permissive for production of Pr55(gag). Not surprisingly, wild-type BH10 RNA was packaged at far higher efficiency than that associated with mutant viral RNA that was deleted of RNA packaging signals and incapable of Pr55(gag) production. However, when production of Pr55(gag) was eliminated from the wild-type BH10 viral RNA by insertion of stop codons either in matrix (MA) or in capsid (CA) sequences, regardless of retention of wild-type RNA packaging signals, these Pr55(gag)-deficient viral RNAs were packaged at low levels similar to those observed with viral RNA species that lack RNA packaging signals and are capable of Pr55(gag) generation. Moreover, loss of Pr55(gag) production did not affect stability of the relevant viral RNA; this observation rules out the possibility that lowered packaging efficiency associated with Pr55(gag)-deficient HIV-1 RNA is a result of reduced RNA stability. Taken together, our data demonstrate that cis translation of Pr55(gag) is needed for efficient packaging of HIV-1 RNA.
authors.affiliation: McGill AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada H3T 1E2. chen.liang@mcgill.ca
authors.forename: Chen
authors.initials: C
authors.lastname: Liang
authors.forename: Jing
authors.initials: J
authors.lastname: Hu
authors.forename: Rodney S
authors.initials: RS
authors.lastname: Russell
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wainberg
mesh_terms: D000818:Animals; D019556:COS Cells; D018076:DNA, Complementary; D004742:Enhancer Elements, Genetic; D015683:Gene Products, gag / Q000378:metabolism*; D015497:HIV-1 / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D014176:Protein Biosynthesis; D011498:Protein Precursors / Q000378:metabolism*; D020038:RNA, Spliced Leader / Q000235:genetics; D012367:RNA, Viral / Q000378:metabolism*; D014162:Transfection; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism; D019065:Virus Assembly
chemical_list: D018076:DNA, Complementary; D015683:Gene Products, gag; D011498:Protein Precursors; D020038:RNA, Spliced Leader; D012367:RNA, Viral; D014764:Viral Proteins; C059767:p55 gag precursor protein, Human immunodeficiency virus 1